These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 11589874)

  • 21. Photophobia accompanied by painful plantar punctate hyperkeratotic patches: Tyrosinemia type 2.
    Mohite AA; Abbott J
    Indian J Ophthalmol; 2018 Mar; 66(3):449. PubMed ID: 29480263
    [No Abstract]   [Full Text] [Related]  

  • 22. Tyrosinaemia type II: an easily diagnosed metabolic disorder with a rewarding therapeutic response.
    al-Essa MA; Rashed MS; Ozand PT
    East Mediterr Health J; 1999 Nov; 5(6):1204-7. PubMed ID: 11924112
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Corneal opacities associated with NTBC treatment.
    Ahmad S; Teckman JH; Lueder GT
    Am J Ophthalmol; 2002 Aug; 134(2):266-8. PubMed ID: 12140036
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An Infant with Bilateral Keratitis: From Infectious to Genetic Diagnosis.
    Thibault LP; Mitchell GA; Parisien B; Hamel P; Blanchard AC
    Am J Case Rep; 2022 Nov; 23():e937967. PubMed ID: 36447403
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcome of tyrosinaemia type III.
    Ellaway CJ; Holme E; Standing S; Preece MA; Green A; Ploechl E; Ugarte M; Trefz FK; Leonard JV
    J Inherit Metab Dis; 2001 Dec; 24(8):824-32. PubMed ID: 11916315
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tyrosinemia type II: Mutation update, 11 novel mutations and description of 5 independent subjects with a novel founder mutation.
    Peña-Quintana L; Scherer G; Curbelo-Estévez ML; Jiménez-Acosta F; Hartmann B; La Roche F; Meavilla-Olivas S; Pérez-Cerdá C; García-Segarra N; Giguère Y; Huppke P; Mitchell GA; Mönch E; Trump D; Vianey-Saban C; Trimble ER; Vitoria-Miñana I; Reyes-Suárez D; Ramírez-Lorenzo T; Tugores A
    Clin Genet; 2017 Sep; 92(3):306-317. PubMed ID: 28255985
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tyrosinemia Type III detected via neonatal screening: management and outcome.
    Heylen E; Scherer G; Vincent MF; Marie S; Fischer J; Nassogne MC
    Mol Genet Metab; 2012 Nov; 107(3):605-7. PubMed ID: 23036342
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Diagnosis of hereditary tyrosinemia type I: clinical study of ten patients].
    Li XY; DU ML; Zhuang SQ
    Zhonghua Er Ke Za Zhi; 2006 Jun; 44(6):470-1. PubMed ID: 16836864
    [No Abstract]   [Full Text] [Related]  

  • 29. Tyrosinemia type 1 and irreversible neurologic crisis after one month discontinuation of nitisone.
    Önenli Mungan N; Yıldızdaş D; Kör D; Horoz ÖÖ; İncecik F; Öktem M; Sander J
    Metab Brain Dis; 2016 Oct; 31(5):1181-3. PubMed ID: 27188289
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatorenal Tyrosinaemia: Impact of a Simplified Diet on Metabolic Control and Clinical Outcome.
    Bärhold F; Meyer U; Neugebauer AK; Thimm EM; Lier D; Rosenbaum-Fabian S; Och U; Fekete A; Möslinger D; Rohde C; Beblo S; Hochuli M; Bogovic N; Korpel V; Dahl SV; Mayorandan S; Fischer A; Freisinger P; Dokoupil K; Heddrich-Ellerbrok M; Jörg-Streller M; van Teeffelen-Heithoff A; Lahl J; Das AM
    Nutrients; 2020 Dec; 13(1):. PubMed ID: 33396520
    [No Abstract]   [Full Text] [Related]  

  • 31. An unfortunate challenge: Ketogenic diet for the treatment of Lennox-Gastaut syndrome in tyrosinemia type 1.
    De Lucia S; Pichard S; Ilea A; Greneche MO; François L; Delanoë C; Schiff M; Auvin S
    Eur J Paediatr Neurol; 2016 Jul; 20(4):674-7. PubMed ID: 27052529
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel and recurrent mutations in the TAT gene in Tunisian families affected with Richner-Hanhart syndrome.
    Bouyacoub Y; Zribi H; Azzouz H; Nasrallah F; Abdelaziz RB; Kacem M; Rekaya B; Messaoud O; Romdhane L; Charfeddine C; Bouziri M; Bouziri S; Tebib N; Mokni M; Kaabachi N; Boubaker S; Abdelhak S
    Gene; 2013 Oct; 529(1):45-9. PubMed ID: 23954227
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Application of succinylacetone levels measurement in the blood and urine in the diagnosis of tyrosinemia type 1].
    Han LS; Ye J; Qiu WJ; Zhang HW; Wang Y; Ji WJ; Gao XL; Li XY; Jin J; Gu XF
    Zhonghua Er Ke Za Zhi; 2012 Feb; 50(2):126-30. PubMed ID: 22455637
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tyrosinemia type II: Novel mutations in TAT in a boy with unusual presentation.
    Gokay S; Kendirci M; Ustkoyuncu PS; Kardas F; Bayram AK; Per H; Poyrazoğlu HG
    Pediatr Int; 2016 Oct; 58(10):1069-1072. PubMed ID: 27285949
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Persistent tyrosinemia detected by thin-layer chromatography.
    Neto EC; Schulte J; Anele E; Becker D; Rubim R; Lewis E; De Mari J; Giugliani R
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 2():151. PubMed ID: 11400756
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The genetic tyrosinemias.
    Scott CR
    Am J Med Genet C Semin Med Genet; 2006 May; 142C(2):121-6. PubMed ID: 16602095
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thygeson's superficial punctate keratitis: ten years' experience.
    Nagra PK; Rapuano CJ; Cohen EJ; Laibson PR
    Ophthalmology; 2004 Jan; 111(1):34-7. PubMed ID: 14711711
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bilateral recurrent pseudodendritic keratopathy as the initial manifestation of tyrosinemia type II.
    Miranda BA; Rocha ACH; Arantes RR; Kanufre VC; Silva SC; Vasconcelos-Santos DV
    Ophthalmic Genet; 2022 Apr; 43(2):282-284. PubMed ID: 35137651
    [No Abstract]   [Full Text] [Related]  

  • 39. A child with dendritiform eye lesions and developmental delay.
    Gliagias V; Denisova K; Kang JJ
    Am J Ophthalmol Case Rep; 2022 Dec; 28():101701. PubMed ID: 36118278
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biochemical and molecular diagnosis of tyrosinemia type I with two novel FAH mutations in a Hong Kong chinese patient: recommendation for expanded newborn screening in Hong Kong.
    Mak CM; Lam CW; Chim S; Siu TS; Ng KF; Tam S
    Clin Biochem; 2013 Jan; 46(1-2):155-9. PubMed ID: 23000314
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.